Making Six Figures but Betting Everything on U.S. Stocks? AVUV Fixes That Problem

You check your portfolio and it looks like every other portfolio in America. Apple, Microsoft, NVIDIA, Amazon, Meta, Alphabet, and a heaping side of S&P 500 index fund that is, when you look under the hood, basically more of the same seven names. You are 38, you have 25-plus years until retirement, and you have a nagging feeling that betting the house on the same handful of trillion-dollar tech giants is not actually diversification. You are right to feel that way, and the ETF that fixes it is the Avantis U.S. Small Cap Value ETF (NYSEARCA:AVUV), a fund built to own everything your index quietly underweights.

Mega-cap growth has carried the market for so long that the average investor now owns almost no exposure to the two factors academic research has identified as the most reliable long-run sources of equity premium: small size and cheap valuation. The fix isn’t to sell your index fund. It’s to add a counterweight. Something that zigs when the Mag 7 zags, with a different earnings stream, a different valuation profile, and a different beta to whatever AI capex does next. That is exactly the role AVUV is built to play.

AVUV is run by Avantis Investors, a unit of American Century, and it is the most popular actively managed small-cap value ETF on the market for a reason. It holds more than 500 positions drawn from the cheapest, most profitable corner of the U.S. small-cap universe. As of the latest filing, fund net assets sat at roughly $23.5 billion, which means you get institutional scale and tight spreads without giving up the active-screening edge.

What does that screening look like in practice? The top holdings are a tour of unloved economic plumbing: Five Below at 0.97% of the fund, GATX at 0.92%, Avnet at 0.79%, Archrock at 0.77%, Dana at 0.73%, Alaska Air at 0.72%, California Resources at 0.71%, and Air Lease at 0.69%, with a long tail of regional banks, retailers, energy names, and industrial cyclicals. The top ten is intentionally free of household tech names, and those ten positions add up to just 7.5% of assets. That is genuinely spread-out exposure rather than a few concentrated bets.

For your portfolio, the cost is minimal. AVUV charges a published expense ratio of 0.25%, meaning roughly $9,975 of every $10,000 stays invested and working for the value factor. And the value factor has been working. AVUV is up 20.38% year to date and 38.82% over the trailing year, with shares closing at $122 on June 18, 2026. Over the trailing five years it has returned 81.73%, well ahead of the 33.07% from the plain-vanilla Russell 2000 proxy IWM over the same span. That gap is the value tilt and the profitability screen earning their keep.

Small-cap value is volatile and cyclical. AVUV slipped 0.97% in the past week while large-cap indices held up, and there will be 12-to-18-month stretches where it lags the S&P badly. The fund is also concentrated in regional banks, retailers, and energy, so a credit cycle or an oil collapse will hurt. This is a long-horizon allocation, not a quick trade.

If your portfolio already looks like the index, the missing piece is the slice of the market that the index underweights and that history says compounds hardest over decades. For a long-horizon investor, AVUV is worth researching as a complement to a core S&P allocation, the counterweight that makes the rest of your portfolio more than just seven stocks in a trench coat.